| 21.26 -0.9 (-4.06%) | 10-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 30.42 |
1-year : | 33.91 |
| Resists | First : | 26.04 |
Second : | 29.04 |
| Pivot price | 22.62 |
|||
| Supports | First : | 21.2 |
Second : | 17.64 |
| MAs | MA(5) : | 21.75 |
MA(20) : | 23.71 |
| MA(100) : | 24.28  |
MA(250) : | 22.55 |
|
| MACD | MACD : | -1.4 |
Signal : | -1.2 |
| %K %D | K(14,3) : | 7.9 |
D(3) : | 8.2 |
| RSI | RSI(14): 25.8 |
|||
| 52-week | High : | 29.72 | Low : | 13.63 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ WRBY ] has closed above bottom band by 23.0%. Bollinger Bands are 40.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 12 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 22.66 - 22.78 | 22.78 - 22.88 |
| Low: | 20.93 - 21.06 | 21.06 - 21.17 |
| Close: | 21.05 - 21.27 | 21.27 - 21.45 |
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Tue, 21 Oct 2025
Warby Parker Inc. (WRBY) Stock Analysis: Evaluating a 22% Potential Upside with Solid Buy Ratings - DirectorsTalk Interviews
Fri, 17 Oct 2025
First Week of June 2026 Options Trading For Warby Parker (WRBY) - Nasdaq
Thu, 16 Oct 2025
Nov 6 Q3 2025 Results Before Market Open — Warby Parker to Host Webcast & 8:00 AM ET Call - Stock Titan
Tue, 07 Oct 2025
Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 4.17% Potential Upside Amidst Strong Revenue Growth - DirectorsTalk Interviews
Tue, 07 Oct 2025
2 Reasons to Watch WRBY and 1 to Stay Cautious - Yahoo Finance
Mon, 06 Oct 2025
Warby Parker: Excellent Management Of Tariffs, Accelerating Growth (NYSE:WRBY) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 105 (M) |
| Shares Float | 88 (M) |
| Held by Insiders | 7.5 (%) |
| Held by Institutions | 95.6 (%) |
| Shares Short | 9,880 (K) |
| Shares Short P.Month | 9,130 (K) |
| EPS | -0.08 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.96 |
| Profit Margin | -1.2 % |
| Operating Margin | -2.1 % |
| Return on Assets (ttm) | -1.6 % |
| Return on Equity (ttm) | -2.7 % |
| Qtrly Rev. Growth | 13.8 % |
| Gross Profit (p.s.) | 4.25 |
| Sales Per Share | 7.8 |
| EBITDA (p.s.) | 0.3 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 117 (M) |
| Levered Free Cash Flow | 44 (M) |
| PE Ratio | -265.75 |
| PEG Ratio | 0 |
| Price to Book value | 7.18 |
| Price to Sales | 2.72 |
| Price to Cash Flow | 19.15 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|